Issue of Equity

Immupharma PLC
05 January 2007





For immediate release                                            5 January 2007

                                 ImmuPharma PLC

                                Issue of Equity

ImmuPharma Plc ('ImmuPharma' or 'the Company') announces that options to
subscribe for 288,000 ordinary shares of 10 pence each in the capital of the
Company have been exercised by former Directors and the new ordinary shares have
now been allotted to them.

Following the above allotment the Company now has 72,776,149 ordinary shares of
10p each in issue.

Application has been made for the admission of 288,000 ordinary shares to
trading on AIM. The shares will rank pari passu with existing ordinary shares
and it is expected that admission will occur on 11 January 2007.

For further information, please contact:
ImmuPharma PLC:
Richard Warr, Chairman                             [phone]

Dawnay, Day Corporate Finance Limited, Nominated adviser
David Floyd                                        [phone]




                      This information is provided by RNS
            The company news service from the London Stock Exchange